Home » Autism. Here comes TeleNIDA, an innovative strategy for early diagnosis

Autism. Here comes TeleNIDA, an innovative strategy for early diagnosis

by admin
Autism.  Here comes TeleNIDA, an innovative strategy for early diagnosis

A telemedicine tool developed thanks to the scientific collaboration, in the COVID era, between the ISS and the IRCCS Eugenio Medea – Bosisio Parini. Researchers and clinicians from the various centers involved have tested and validated its effectiveness, describing the results in the journal Journal of Autism and Developmental Disorders

25 FEB

A new remote screening tool makes it possible to identify signs of autism risk from 18 months of age. It is teleNIDA, a telemedicine tool developed thanks to the scientific collaboration, in the COVID era, between the ISS and the IRCCS Eugenio Medea – Bosisio Parini. Researchers and clinicians from the various centers involved have tested and validated its effectiveness, describing the results in the journal Journal of Autism and Developmental Disorders.

“Through the Italian Network for the Early Recognition of Autism Spectrum Disorders (NIDA) – declares Dr. Maria Luisa Scattonicoordinator of the National Autism Observatory of the ISS – it was possible to make a specialist evaluation of possible autism indicators on a sample of video images collected by parents, suitably guided by experts in the early diagnosis of autism”.

The NIDA was established thanks to funding from the Ministry of Health and is currently present in all the main branches of the National Health Service. “The NIDA – continues Dr. Scattoni – is configured as a scientific and operational infrastructure capable of implementing innovative tools and strategies to respond to the needs of people with autism and their families. The experimentation of teleNIDA is a virtuous example of scientific collaboration that derives from the international reality suitably adapted to the Italian context. The results of this work enhance the experience of Italian professionals and testify to the possibility of implementing multi-centre clinical research actions in the public health service”.

See also  Smo, the IIT startup that sells smartphone microscopes to US universities

February 25, 2023
© breaking latest news


Other articles in Science and Drugs

image_1

image_2

image_3

image_4

image_5

image_6

Quotidianosanità.it

Online newspaper
of health information.

QS Editions srl

P.I. 12298601001

Registered office:
Via Giacomo Peroni, 400
00131 – Roma

Operational headquarters:
Via della Stelletta, 23
00186 – Roma

Site Manager

Luciano Fassari

Editorial director
Francesco Maria Avitto

President
Ernesto Rodriguez

    Joint Venture

  • SICS srl
  • Editions
    Health Communication
    srl

Copyright 2013 © QS Edizioni srl. All rights reserved
– P.I. 12298601001
– registration in the ROC n. 23387
– registration with the Court of Rome n. 115/3013 of 05/22/2013

All rights reserved.
Policy privacy

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy